Related Experiment Video

Updated: Jul 14, 2026

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

Antibodies against RAGE in sepsis and inflammation: implications for therapy

Emily C Lutterloh, Steven M Opal

    Expert Opinion on Pharmacotherapy
    |June 15, 2007
    PubMed

    Insights

    The receptor for advanced glycation end products (RAGE) is a potential target for treating sepsis and inflammation. Anti-RAGE antibodies show promise, but further research using advanced techniques is needed.

    Area of Science:

    • Biochemistry
    • Immunology
    • Pathophysiology

    Background:

    • Sepsis and inflammatory processes involve complex mechanisms.
    • The receptor for advanced glycation end products (RAGE) plays a role in inflammation and sepsis.
    • Anti-RAGE antibodies have been investigated for potential therapeutic benefits.

    Discussion:

    • RAGE's characteristics suggest it is an attractive target for novel therapies.
    • The incomplete understanding of sepsis and inflammation pathophysiology presents a challenge.
    • Advanced computational and genomic techniques may be crucial for developing targeted therapies.

    Key Insights:

    • RAGE is implicated in inflammatory conditions and sepsis.
    • Anti-RAGE antibody therapy is a promising avenue for research.
    • Understanding complex disease pathways requires innovative approaches.

    Outlook:

    • Further investigation into RAGE as a therapeutic target is warranted.
    • Computational simulation and genomics offer new tools for dissecting inflammatory diseases.
    • Developing targeted therapies for sepsis and inflammation remains a critical research goal.

    More Related Videos

    Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies07:34

    Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

    Published on: April 11, 2012

    Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis05:28

    Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

    Published on: December 9, 2022

    Related Concept Videos

    Acute Inflammation III: Local and Systemic Effects01:25

    Acute Inflammation III: Local and Systemic Effects

    Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
    Rheumatic Heart Disease I: Introduction01:23

    Rheumatic Heart Disease I: Introduction

    Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
    Humoral Immune Responses01:36

    Humoral Immune Responses

    Overview
    Hypersensitivity Reactions: Cytolytic Reactions01:01

    Hypersensitivity Reactions: Cytolytic Reactions

    Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...